Vircon Legal advised Şirket Ortağım on its investment in Hibrigen. The transaction closed on 31 January 2019. The financial terms of the round were not disclosed at the request of the parties.
Şirket Ortağım operated as a structured early-stage capital channel in the Turkish ecosystem, bringing institutional discipline to seed-stage transactions where the company profile fit the platform’s deployment thesis. Deep-technology and applied-science investments at this stage carry structural considerations that distinguish them from pure consumer or pure software early-stage transactions — the technical validation horizon is typically longer, the path from prototype to commercial deployment depends on industrial or research partnerships, and the IP architecture has to be set up to support both commercial deployment and ongoing R&D activity.
Vircon Legal advised Şirket Ortağım on transaction structuring, subscription documentation, valuation mechanics, investor-rights and governance design, information-flow expectations, follow-on protection mechanics, IP-and-research-output protection alignment relevant to the underlying technical category, and the documentation architecture that lets a structured early-stage investor operate consistently across multiple portfolio companies. Investor-side counsel for deep-technology seed investments focuses on aligning the round terms with the realistic cadence of subsequent technical and commercial milestones — capital and validation horizons in these categories typically extend further than pure-software seed rounds.
This transaction joins our wider track record advising institutional and structured-network investors on early-stage Turkish technology deployments. For more on our institutional-investor and angel-network practice, see our Investment Management and M&A and Investments pages.
